577 related articles for article (PubMed ID: 20954189)
1. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases.
Marin GG; Cardiel MH; Cornejo H; Viveros ME
J Clin Rheumatol; 2009 Oct; 15(7):325-9. PubMed ID: 20009966
[TBL] [Abstract][Full Text] [Related]
3. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.
Mahler M; Hanly JG; Fritzler MJ
Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330
[TBL] [Abstract][Full Text] [Related]
4. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
5. Distinctive features of positive anti-cell antibody tests (indirect immunofluorescence on HEp-2 cells) in patients with non-autoimmune diseases.
Agustinelli RA; Rodrigues SH; Mariz HA; Prado MS; Andrade LEC
Lupus; 2019 Apr; 28(5):629-634. PubMed ID: 31027463
[TBL] [Abstract][Full Text] [Related]
6. Anti-DFS70 antibodies in 597 healthy hospital workers.
Watanabe A; Kodera M; Sugiura K; Usuda T; Tan EM; Takasaki Y; Tomita Y; Muro Y
Arthritis Rheum; 2004 Mar; 50(3):892-900. PubMed ID: 15022332
[TBL] [Abstract][Full Text] [Related]
7. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-nuclear antibodies by indirect immunofluorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases.
Brito Fde A; Santos SM; Ferreira GA; Pedrosa W; Gradisse J; Costa LC; Neves SP
Rev Bras Reumatol; 2014; 54(1):13-20. PubMed ID: 24878786
[TBL] [Abstract][Full Text] [Related]
9. The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.
Dellavance A; Viana VS; Leon EP; Bonfa ES; Andrade LE; Leser PG
J Rheumatol; 2005 Nov; 32(11):2144-9. PubMed ID: 16265692
[TBL] [Abstract][Full Text] [Related]
10. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
11. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
12. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
13. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
[TBL] [Abstract][Full Text] [Related]
14. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
15. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
17. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
Almogren A
Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
[TBL] [Abstract][Full Text] [Related]
18. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of antinuclear antibody measurement using different cells as nuclear substrates].
Yang JS; Hsieh RP; Shen MC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):299-310. PubMed ID: 1818799
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method].
Kang SY; Lee WI
Korean J Lab Med; 2009 Apr; 29(2):145-51. PubMed ID: 19411782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
